Fresenius Medical Care AG & Co. KGaA (FMS) Stock Forecast, Price & News

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last year. There are currently 2 sell ratings and 7 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares.
View FMS analyst ratings or view top-rated stocks.

9 Wall Street research analysts have issued twelve-month price targets for Fresenius Medical Care AG & Co. KGaA's shares. Their FMS share price forecasts range from $11.70 to $51.80. On average, they anticipate the company's stock price to reach $28.45 in the next year. This suggests a possible upside of 25.2% from the stock's current price.
View analysts price targets for FMS or view top-rated stocks among Wall Street analysts.

Fresenius Medical Care AG & Co. KGaA's stock was trading at $16.34 on January 1st, 2023. Since then, FMS stock has increased by 39.0% and is now trading at $22.72.
View the best growth stocks for 2023 here.

Fresenius Medical Care AG & Co. KGaA saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 1,510,000 shares, a decrease of 7.9% from the April 30th total of 1,640,000 shares. Based on an average daily volume of 900,300 shares, the days-to-cover ratio is currently 1.7 days.
View Fresenius Medical Care AG & Co. KGaA's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our FMS earnings forecast.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) announced its quarterly earnings data on Tuesday, May, 9th. The company reported $0.28 earnings per share for the quarter, topping analysts' consensus estimates of $0.18 by $0.10. The firm earned $5.05 billion during the quarter, compared to the consensus estimate of $4.98 billion. Fresenius Medical Care AG & Co. KGaA had a trailing twelve-month return on equity of 5.44% and a net margin of 3.06%.

Fresenius Medical Care AG & Co. KGaA announced an annual dividend on Wednesday, May 3rd. Investors of record on Thursday, May 18th will be paid a dividend of $0.7086 per share on Thursday, June 1st. This represents a yield of 2.1%. The ex-dividend date of this dividend is Wednesday, May 17th.
Read our dividend analysis for FMS.

ETFs with the largest weight of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) stock in their portfolio include Invesco International Dividend Achievers ETF (PID), Cultivar ETF (CVAR), Pacer Global Cash Cows Dividend ETF (GCOW) and Pacer Trendpilot European Index ETF (PTEU).Avantis Responsible International Equity ETF (AVSD) and

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) pays an annual dividend of $0.42 per share and currently has a dividend yield of 1.82%. The dividend payout ratio is 39.62%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 28.00% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FMS.

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).

Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

Fresenius Medical Care AG & Co. KGaA's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Pzena Investment Management LLC (3.41%), Dodge & Cox (0.72%), Balyasny Asset Management L.P. (0.13%), Arrowstreet Capital Limited Partnership (0.12%), BlackRock Inc. (0.08%) and Two Sigma Advisers LP (0.04%).

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of FMS stock can currently be purchased for approximately $22.72.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has a market capitalization of $13.33 billion and generates $20.44 billion in revenue each year. The company earns $709.50 million in net income (profit) each year or $1.06 on an earnings per share basis.

The company employs 1,235 workers across the globe.

Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The official website for the company is www.freseniusmedicalcare.com. The company can be reached via phone at (496) 172-6090, via email at ir@fmc-ag.com, or via fax at 49-6172-609-2301.